REGN Historical Earnings image   This REGN historical earnings page last updated 5/6/2022
REGN Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20225/4/20222.96B
Q4 20212/4/20224.95B
Q3 202111/4/20213.45B
Q2 20218/5/20215.14B
Q1 20215/6/20212.53B
Q4 20202/5/20212.42B
Q3 202011/5/20202.29B
Q2 20208/5/20201.95B
Q1 20205/5/20201.83B
Q4 20192/6/20202.17B
Q3 201911/5/20192.05B
Q2 20198/6/20191.93B
Q1 20195/7/20191.71B
Q4 20182/6/20191.93B
Q3 201811/6/20181.66B
Q2 20188/2/20181.61B
Q1 20185/3/20181.51B
Q4 20172/8/20181.58B
Q3 201711/8/20171.50B
Q2 20178/3/20171.47B
Q1 20175/4/20171.32B
Q4 20162/9/20171.23B
Q3 201611/4/20161.22B
Q2 20168/4/20161.21B
Q1 20165/5/20161.20B
Q4 20152/9/20161.10B
Q3 201511/4/20151.14B
Q2 20158/4/2015998.62M
Q1 20155/7/2015869.61M
Q4 20142/10/2015802.33M
Q3 201411/4/2014726.00M
Q2 20148/5/2014666.00M
Q1 20145/8/2014625.70M
Q4 20132/11/2014610.00M
Q3 201311/5/2013597.00M
Q2 20138/6/2013458.00M
Q1 20135/3/2013439.66M
Q4 20122/14/2013414.61M
Q3 201210/25/2012427.70M
Q2 20127/25/2012304.40M
Q1 20125/1/2012231.79M
REGN Historical Earnings EPS
Data adjusted for REGN split history

PeriodHistorical Earnings DateAdj. EPS
Q1 20225/4/202211.490
Q4 20212/4/202223.720
Q3 202111/4/202115.370
Q2 20218/5/202125.800
Q1 20215/6/20219.890
Q4 20202/5/20219.530
Q3 202011/5/20208.360
Q2 20208/5/20207.160
Q1 20205/5/20206.600
Q4 20192/6/20207.500
Q3 201911/5/20196.670
Q2 20198/6/20196.040
Q1 20195/7/20194.450
Q4 20182/6/20196.84
Q3 201811/6/20185.87
Q2 20188/2/20185.45
Q1 20185/3/20184.67
Q4 20172/8/20185.23
Q3 201711/8/20173.99
Q2 20178/3/20174.17
Q1 20175/4/20172.92
Q4 20162/9/20173.04
Q3 201611/4/20163.13
Q2 20168/4/20162.82
Q1 20165/5/20162.57
Q4 20152/9/20162.83
Q3 201511/4/20153.47
Q2 20158/4/20152.89
Q1 20155/7/20152.88
Q4 20142/10/20152.79
Q3 201411/4/20142.52
Q2 20148/5/20142.47
Q1 20145/8/20142.26
Q4 20132/11/20142.24
Q3 201311/5/20132.4
Q2 20138/6/20130.79
Q1 20135/3/20131.78
Q4 20122/14/20134.08
Q3 201210/25/20121.89
Q2 20127/25/20120.9
Q1 20125/1/20120.11
Quotes delayed 20 minutes

Email EnvelopeFree REGN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Regeneron Pharmaceuticals (REGN) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

REPH Past Earnings
REPL Past Earnings
RETA Past Earnings
RGEN Past Earnings
RGLS Past Earnings
RGNX Past Earnings
RIGL Past Earnings
RLAY Past Earnings
RLMD Past Earnings
RLYB Past Earnings
What was the record high REGN historical earnings result?
In terms of earnings or revenue, what is the best REGN historical earnings result that Regeneron Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest REGN historical earnings result was set in Q2 2021, when Regeneron Pharmaceuticals posted results of 25.800/share. The most successful revenue quarter within our data set was Q2 2021 when Regeneron Pharmaceuticals reported revenue of 5.14B.

What was the lowest Regeneron Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest REGN has reported, and when?

✔️Accepted answer: Within our data set, the lowest REGN historical earnings result was set in Q1 2012, when Regeneron Pharmaceuticals posted results of 0.11/share. The smallest revenue quarter within our data set was Q1 2012 when Regeneron Pharmaceuticals reported revenue of 231.79M.

On this page we presented the REGN historical earnings date information for Regeneron Pharmaceuticals. Reviewing that REGN Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q2 2021, when REGN posted adjusted EPS of 25.800/share. Meanwhile the lowest REGN historical earnings result was in Q1 2012, when REGN posted adjusted EPS of 0.11/share. Moving to Regeneron Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2021 when REGN reported 5.14B in revenue, while the smallest revenue quarter was Q1 2012 when REGN reported 231.79M in revenue.

For self directed investors doing their due diligence on REGN or any other given stock, their research can benefit from looking into all of the Regeneron Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Regeneron Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for REGN. Thanks for visiting, and the next time you need to research REGN historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: ACL Historical Stock Prices, CRI Price Target, Top Ten Hedge Funds Holding FNF.

 

REGN Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.